Brazil Secures 25,000 Mpox Vaccine Doses Amid Global Shortage
Health Ministry expands immunization supply through direct negotiations with Danish manufacturer to bolster stocks.
1Expanded Vaccine Procurement
The Brazilian Ministry of Health successfully negotiated the acquisition of 25,000 mpox vaccine doses. This deal significantly increases the previous allocation of 5,000 units to 20,000, with delivery expected within three weeks. The supply was secured through direct discussions with the sole Danish manufacturer currently certified by the World Health Organization.
2Distribution and Current Stock
Nine federal units have already received an initial batch of 3,650 doses to address rising infection rates. Key regions including Rio de Janeiro, Ceará, and the Federal District are among the prioritized areas. These new arrivals are intended to reinforce the national stockpile as officials manage the limited global supply chain.
3Intradermal Application Strategy
To maximize the impact of limited supplies, the Ministry issued a technical note recommending intradermal vaccine application. This method, already utilized in Europe, allows for up to five times more people to be vaccinated using a single dose. This clinical adjustment is crucial for managing resources during the ongoing global shortage.
4Mpox Epidemiological Context
As of November 6, Brazil has confirmed 832 cases of mpox and recorded one death. The virus, which belongs to the Orthopoxvirus genus, primarily causes skin lesions and rashes. Infections are currently concentrated in São Paulo, Rio de Janeiro, Ceará, and the Federal District, where health authorities are monitoring the outbreak closely.
5Transmission and Prevention
The virus spreads through direct contact with infected skin lesions, bodily secretions, or contaminated objects like linens and towels. Prolonged respiratory contact also poses a significant risk. While symptoms typically last two to four weeks, including fever and muscle pain, most cases currently exhibit mild to moderate clinical progression across the country.
6Targeted Vaccination Policy
The World Health Organization does not recommend mass vaccination for mpox. Brazil follows this guidance, focusing exclusively on high-risk groups, such as individuals living with HIV/AIDS with specific CD4 counts, laboratory professionals handling samples, and those who have had high-risk contact with confirmed cases. Vaccination is conducted only at specialized centers.
7Vaccination Protocol Details
The standard immunization schedule requires two doses administered with a 28-day interval between them. Patients must seek evaluation from health surveillance services to qualify for the vaccine. It is important to note that vaccination does not replace standard hygiene measures, such as frequent handwashing and the sanitization of shared surfaces.
8Strategic Public Health Outlook
The reliance on a single global manufacturer highlights the vulnerability of the current mpox response. By optimizing application techniques and prioritizing vulnerable populations, the Ministry aims to mitigate the impact of the disease. Authorities continue to urge citizens to seek medical guidance if they have been in contact with suspected cases.
Original article: Agência Brasil — Brazil Secures 25,000 Mpox Vaccine Doses Amid Global Shortage